OÜ X7 Clinicals and Pharmaceuticals Research EU
RegisteredKey figures
Ratios
2025Summary: OÜ X7 Clinicals and Pharmaceuticals Research EU
What kind of company is it?
OÜ X7 Clinicals and Pharmaceuticals Research EU (registry code 14119880) is a private limited company (OÜ). The company was entered in the Commercial Register in 2016 and has been registered for 10 years. Registered location: Kesklinna linnaosa, Tallinn, Harju maakond. According to the latest annual report, the main activity is research and development in natural sciences and engineering (EMTAK 72101). The company is registered for VAT (VAT number EE102168471).
How is the company doing financially?
Revenue in financial year 2025 was 72 816 €, down 28,8% on the previous year (102 287 €). From 2019 to 2025, revenue grew by an average of 13,8% per year. Financial year 2025 ended with a loss of 254 €. The company was profitable in 3 of the 7 published financial years. According to the report, the company had no employees in financial year 2025. At the end of financial year 2025, total assets were 31 576 € and equity 21 039 € (66,6% of assets).
What do the latest quarters show?
According to the Tax and Customs Board, turnover in Q3 2026 was 23 512 €, up 387% on the same quarter a year earlier.
Who runs the company and who owns it?
The management board has 2 members. The sole owner of the company is a private individual.
Where does the data come from and how fresh is it?
Register data (name, address, legal form, management board and owners) come from the Commercial Register of the Centre of Registers and Information Systems (RIK); changes are read from RIK every night. Financial figures come from annual reports; the latest report (financial year 2025) was filed on 05.06.2026. Quarterly turnover, employee numbers and labour taxes come from the open data of the Tax and Customs Board (EMTA); latest quarter Q3 2026. Changes, averages and ratios are calculated by entity.ee from open data and are not an official assessment.
Quarterly figures
| Quarter | Revenue | Number of employees | Labour taxes |
|---|---|---|---|
| Q3 2026 | 23 512 € | — | 0 € |
| Q2 2026 | 701 € | — | 0 € |
| Q1 2026 | 33 911 € | — | 0 € |
| Q4 2025 | 18 326 € | — | — |
| Q3 2025 | 4828 € | — | 0 € |
| Q2 2025 | 12 661 € | — | 0 € |
| Q1 2025 | 29 399 € | — | — |
Source: Tax Board open data — based on VAT returns, may not exactly match revenue in the annual report. Updated quarterly.
Dividends
calculatedDistributed as dividends 2106 € (9% of distributable profit).
Summary of financial statements2021–2025
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Sales revenue | 107 812 | 137 344 | 163 220 | 102 287 | 72 816 |
| Net profit | 45 563 | −23 099 | −12 772 | 9946 | −254 |
| Retained earnings | 3761 | 49 324 | 26 225 | 13 453 | 21 293 |
| Total assets | 66 137 | 169 442 | 138 314 | 157 486 | 31 576 |
| Total liabilities | 14 313 | 143 217 | 124 861 | 134 087 | 10 537 |
| Total equity | 51 824 | 26 225 | 13 453 | 23 399 | 21 039 |
| Employees | 0 | 0 | 0 | 0 | 0 |
| Calculated dividend | 0 | 0 | 0 | 0 | 2106 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Risks and obligationsAll clear
Data from public registers, not a credit rating.
Connections graph
Click a node to see its other connections.
Annual reportsPDF, XBRL
Loading list of reports…
Source: e-Business Register (RIK). Files open/download directly from the official register.
Related companies
- Exodim OÜ53,2 m €
- IPF Digital AS49,7 m €
- Roche Eesti Osaühing48,4 m €
- VG Estonia OÜ32,8 m €
- Hevi Optronics OÜ27,2 m €